431 related articles for article (PubMed ID: 1904799)
21. Studies of Bence Jones proteins by immunonephelometry.
Levinson SS
Ann Clin Lab Sci; 1992; 22(2):100-9. PubMed ID: 1562164
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
23. Restricted electrophoretic heterogeneity of immunoglobulin light chains in urine: a cause for confusion with Bence Jones protein.
MacNamara EM; Aguzzi F; Petrini C; Higginson J; Gasparro C; Bergami MR; Bianchi G; Whicher JT
Clin Chem; 1991 Sep; 37(9):1570-4. PubMed ID: 1909942
[TBL] [Abstract][Full Text] [Related]
24. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
[TBL] [Abstract][Full Text] [Related]
25. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
26. The urinary light-chain ladder pattern. A product of improved methodology that may complicate the recognition of Bence Jones proteinuria.
Bailey EM; McDermott TJ; Bloch KJ
Arch Pathol Lab Med; 1993 Jul; 117(7):707-10. PubMed ID: 8323434
[TBL] [Abstract][Full Text] [Related]
27. Interference of polyclonal free light chains with identification of Bence Jones proteins.
Hess PP; Mastropaolo W; Thompson GD; Levinson SS
Clin Chem; 1993 Aug; 39(8):1734-8. PubMed ID: 8353965
[TBL] [Abstract][Full Text] [Related]
28. Turbidimetric measurement of Bence-Jones proteins using antibodies against free light chains of immunoglobulins. An artifact caused by different polymeric forms of light chains.
Heino J; Rajamäki A; Irjala K
Scand J Clin Lab Invest; 1984 Apr; 44(2):173-6. PubMed ID: 6426036
[TBL] [Abstract][Full Text] [Related]
29. [Organ-specific nodular pulmonary amyloidosis of the A lambda type in Sjogren syndrome].
Schneider F; Linke RP; Albrecht HJ
Z Arztl Fortbild (Jena); 1997 Jan; 90(8):719-23. PubMed ID: 9133112
[TBL] [Abstract][Full Text] [Related]
30. Proteinuria in multiple myeloma and related diseases.
Ganeval D; Lacour B; Chopin N; Grünfeld JP
Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083
[TBL] [Abstract][Full Text] [Related]
31. Response to therapy in IgG myeloma patients excreting lambda or kappa light chains: CALGB experience.
Cornell CJ; McIntyre OR; Kochwa S; Weksler BB; Pajak TF
Blood; 1979 Jul; 54(1):23-9. PubMed ID: 109133
[TBL] [Abstract][Full Text] [Related]
32. Differences identified between serum and urine immunofixation electrophoresis.
Tracy E; Andrews DM; Constantin MA; Zhu Y
Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of urinary protein in primary systemic amyloidosis (AL).
Gertz MA; Kyle RA
Am J Clin Pathol; 1990 Sep; 94(3):313-7. PubMed ID: 2118721
[TBL] [Abstract][Full Text] [Related]
34. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
Halushka MK; Eng G; Collins AB; Judge DP; Semigran MJ; Stone JR
J Cardiovasc Transl Res; 2015 Jun; 8(4):264-8. PubMed ID: 25925232
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
36. Patient-specific microheterogeneity patterns of monoclonal immunoglobulin light chains as revealed by high resolution, two-dimensional electrophoresis.
Harrison HH
Clin Biochem; 1992 Aug; 25(4):235-43. PubMed ID: 1525978
[TBL] [Abstract][Full Text] [Related]
37. κ and λ urine free light chains: a new method for quantification.
Giussani M; Ciniselli CM; Macciotta A; Panella R; Verderio P; Bonini C; Morelli D
Tumori; 2020 Dec; 106(6):457-463. PubMed ID: 31955649
[TBL] [Abstract][Full Text] [Related]
38. [The clinical significance of serum free light chain in primary systemic amyloidosis].
Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
[TBL] [Abstract][Full Text] [Related]
39. POEMS Syndrome with IgG-λ/IgA-κ Biclonal Gammopathy and Abnormal Serum Free Light Chain Ratio: a Case Report.
Ham JY; Suh JS; Lee WK; Song KE
Ann Clin Lab Sci; 2015; 45(6):702-6. PubMed ID: 26663802
[TBL] [Abstract][Full Text] [Related]
40. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
